APYX
Price
$2.41
Change
-$0.10 (-3.98%)
Updated
Oct 22 closing price
Capitalization
101.52M
14 days until earnings call
Intraday BUY SELL Signals
EMBC
Price
$6.86
Change
+$0.18 (+2.69%)
Updated
Oct 22 closing price
Capitalization
388.68M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APYX vs EMBC

APYX vs EMBC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APYX vs. EMBC commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and EMBC is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for APYX with price predictions
Oct 22, 2026

APYX's Indicator enters downward trend

The Aroon Indicator for APYX entered a downward trend on October 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 248 similar instances where the Aroon Indicator formed such a pattern. In 239 of the 248 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APYX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where APYX's RSI Oscillator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on APYX as a result. In 83 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for APYX just turned positive on October 12, 2026. Looking at past instances where APYX's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

Following a +3.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where APYX advanced for three days, in 198 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

APYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.521) is normal, around the industry mean (2.874). P/E Ratio (-12.050) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.196) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. APYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for EMBC with price predictions
Oct 22, 2026

Aroon Indicator for EMBC shows an upward move is likely

EMBC's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 147 similar instances where the Aroon Indicator showed a similar pattern. In 117 of the 147 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on EMBC as a result. In 58 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for EMBC just turned positive on October 13, 2026. Looking at past instances where EMBC's MACD turned positive, the stock continued to rise in 31 of 40 cases over the following month. The odds of a continued upward trend are 77%.

Following a +6.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMBC advanced for three days, in 188 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

EMBC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.634) is normal, around the industry mean (4.961). P/E Ratio (4.573) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.006) settles around the average of (0.005) among similar stocks. P/S Ratio (0.300) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. EMBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
APYX: Fundamental Ratings
APYX
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APYXEMBC
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (APYX: $2.51 vs. EMBC: $6.68)
Brand notoriety: APYX and EMBC are both not notable
APYX represents the Medical/Nursing Services, while EMBC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APYX: 45% vs. EMBC: 60%
Market capitalization -- APYX: $101.52M vs. EMBC: $388.68M
APYX [@Medical/Nursing Services] is valued at $101.52M. EMBC’s [@Pharmaceuticals: Other] market capitalization is $388.68M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 2 FA rating(s) are green while EMBC’s FA Score has 2 green FA rating(s).

  • APYX’s FA Score: 2 green, 3 red.
  • EMBC’s FA Score: 2 green, 3 red.
According to our system of comparison, EMBC is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 5 TA indicator(s) are bullish while EMBC’s TA Score has 4 bullish TA indicator(s).

  • APYX’s TA Score: 5 bullish, 3 bearish.
  • EMBC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APYX is a better buy in the short-term than EMBC.

Price Growth

APYX (@Medical/Nursing Services) experienced а -2.33% price change this week, while EMBC (@Pharmaceuticals: Other) price change was +8.09% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

APYX is expected to report earnings on Nov 05, 2026.

EMBC is expected to report earnings on Nov 24, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
APYX
Daily Signal:
Gain/Loss:
EMBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

APYX and

Correlation & Price change

A.I.dvisor tells us that APYX and ITOC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APYX and ITOC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-3.98%
ITOC - APYX
26%
Poorly correlated
-8.24%
CLPT - APYX
25%
Poorly correlated
N/A
EMBC - APYX
25%
Poorly correlated
+2.69%
A - APYX
25%
Poorly correlated
-2.17%
NVNO - APYX
25%
Poorly correlated
-5.73%
More

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+2.69%
WAT - EMBC
37%
Loosely correlated
-0.41%
MTD - EMBC
37%
Loosely correlated
+0.40%
AVTR - EMBC
37%
Loosely correlated
-0.64%
RVTY - EMBC
36%
Loosely correlated
+0.48%
RGEN - EMBC
35%
Loosely correlated
-0.72%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
AION.X0.001915-0.000061
-3.09%
AION 5100 cryptocurrency
FIDA.X0.018186-0.000818
-4.31%
Bonfida cryptocurrency
ACM.X0.249636-0.012287
-4.69%
AC Milan Fan Token cryptocurrency
STRK.X0.053219-0.004145
-7.23%
Starknet cryptocurrency
EDU.X0.065980-0.006539
-9.02%
Open Campus cryptocurrency